Your browser doesn't support javascript.
loading
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience.
Razvi, Yousuf; Porcari, Aldostefano; Di Nora, Concetta; Patel, Rishi K; Ioannou, Adam; Rauf, Muhammad U; Masi, Ambra; Law, Steven; Chacko, Liza; Rezk, Tamer; Ravichandran, Sriram; Gilbertson, Janet; Rowczenio, Dorota; Blakeney, Iona J; Kaza, Nandita; Hutt, David F; Lachmann, Helen; Wechalekar, Ashutosh; Moody, William; Lim, Sern; Chue, Colin; Whelan, Carol; Venneri, Lucia; Martinez-Naharro, Ana; Merlo, Marco; Sinagra, Gianfranco; Livi, Ugolino; Hawkins, Philip; Fontana, Marianna; Gillmore, Julian D.
Affiliation
  • Razvi Y; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Porcari A; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Di Nora C; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Patel RK; Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Ioannou A; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Rauf MU; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Masi A; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Law S; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Chacko L; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Rezk T; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Ravichandran S; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Gilbertson J; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Rowczenio D; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Blakeney IJ; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Kaza N; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Hutt DF; Imperial College London, London, United Kingdom.
  • Lachmann H; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Wechalekar A; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Moody W; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Lim S; Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Chue C; Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Whelan C; Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Venneri L; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Martinez-Naharro A; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Merlo M; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Sinagra G; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Livi U; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Hawkins P; Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Fontana M; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
  • Gillmore JD; Division of Medicine, National Amyloidosis Centre, Royal Free Hospital, University College London, London, United Kingdom.
Front Cardiovasc Med ; 9: 1075806, 2022.
Article in En | MEDLINE | ID: mdl-36741843
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Cardiovasc Med Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Cardiovasc Med Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland